|
2023
|
Invention
|
Combination use of wt1 antigen peptide and immunomodulator.
The invention relates to a combinati... |
|
2022
|
Invention
|
Pharmaceutical composition and method for treating or preventing cancer.
The present disclosure ... |
|
|
Invention
|
Pharmaceutical composition and method for treatment or prevention of cancer. THE present inventio... |
|
|
Invention
|
Immunotherapy for angiogenic disease.
The present invention provides a pharmaceutical compositio... |
|
2021
|
Invention
|
Pharmaceutical composition for treating cancer.
The present disclosure includes a pharmaceutical... |
|
|
Invention
|
Pharmaceutical composition for treating cancer. The present disclosure includes a pharmaceutical ... |
|
2020
|
Invention
|
Antigen-specific helper t-cell receptor genes.
The present invention pertains to polynucleotides... |
|
|
Invention
|
Cancer antigen helper peptide. The present invention relates to a WT1 peptide which has an amino ... |
|
|
Invention
|
Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them.
Disc... |
|
|
Invention
|
Method for activating helper t cell. The present invention relates to a method for activating hel... |
|
|
Invention
|
Method for selecting subject likely benefiting from pharmaceutical composition for treating or pr... |
|
2019
|
Invention
|
Immunotherapy for angiogenic disease. The present invention provides a pharmaceutical composition... |
|
|
Invention
|
Composition for preventing or treating benign tumor. 35 helper peptide. In another aspect, provid... |
|
|
Invention
|
Prophylactic or therapeutic drug for benign tumor. 1263535 helper peptide. In another aspect, pro... |
|
|
Invention
|
Cancer vaccine composition. A cancer vaccine composition for human leukocyte antigen (HLA)-A*0206... |
|
2018
|
Invention
|
Conjugate of wt1-derived peptides and composition comprising the same.
The present disclosure in... |
|
|
Invention
|
Conjugate of wt1-derived peptide and composition including same. The present disclosure relates t... |
|
|
Invention
|
Novel cancer antigen eef2.
The present invention provides a method for detecting cancer using a ... |
|
|
Invention
|
Method for activation of helper t cell and composition for use in the method. Disclosed are: a me... |
|
|
Invention
|
Antigen-specific helper t-cell receptor genes. + T-cells, the treatment of cancer, etc. |
|
|
Invention
|
Wt1 antigen peptide conjugate vaccine. A compound represented by the formula (1):
1 is a hydroge... |
|
|
Invention
|
Wt1 cancer antigen peptides and peptide conjugates comprising the peptides.
The present disclosu... |
|
|
Invention
|
Wt1 cancer antigen peptide and peptide conjugate body containing same. The present invention pert... |
|
|
Invention
|
Hla-dr-binding antigen peptide derived from wt1. The present invention provides a WT1-derived HLA... |
|
2017
|
Invention
|
Wt1 helper peptides and combinations of wt1 helper peptide and conjugate of cancer antigen peptid... |
|
|
Invention
|
Wt1 helper peptide, and combination of said peptide and cancer antigen peptide conjugate. The pre... |
|
|
Invention
|
Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same.
An HLA-A*... |
|
2016
|
Invention
|
Method for measuring anti-wt1 antibody.
Provided is an invention relating to a method for measur... |
|
|
Invention
|
Combination therapy with wt1 peptide vaccine and temozolomide.
The present invention relates to ... |
|
|
Invention
|
Combination of wt1 antigen peptide and immunomodulator. The present invention pertains to the com... |
|
|
Invention
|
Tumor antigen based on products of the tumor suppressor gene wt1.
A tumor antigen that comprises... |
|
|
Invention
|
Method for cancer immunotherapy. A novel compound of the formula (1):
3 is a hydrogen atom or an... |
|
|
Invention
|
Cancer antigen helper peptide.
The present invention relates to a WT1 peptide which has an amino... |
|
2015
|
Invention
|
Wt1 antigen peptide conjugate vaccine.
A compound represented by the formula (1):
A compound r... |
|
|
Invention
|
Method for modifying t cell population. Provided is a method for increasing the proportion of mem... |
|
|
Invention
|
Immunotherapy for angiogenic disease. Provided is a medicinal composition for treating and preven... |
|
|
Invention
|
Pharmaceutical composition for injection. (a) one or more kinds of peptides selected from a pepti... |
|
|
Invention
|
Cancer antigen eef2. The present invention provides a method for detecting cancer using a protein... |
|
|
Invention
|
Cancer vaccine composition.
A cancer vaccine composition for human leukocyte antigen (HLA)-A*020... |
|
2014
|
Invention
|
Method for predicting clinical effect of immunotherapy. Provided is a method for predicting a cli... |
